Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia

Clinical trial NCT00139906 · COMPLETED

Trial details

NCT number: NCT00139906
Sponsor: Solvay Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2005-08-01
Primary completion: 2006-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.